Skip to main content
Top
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Parkinson's Disease | Research

Prevalence of Parkinson’s disease among adults aged 45 years and older in China: a cross-sectional study based on the China health and retirement longitudinal study

Authors: Detao Meng, Jiayu Wu, Xinyu Huang, Xiaoxiao Liang, Boyan Fang

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Background

In recent decades, China has experienced a rapid increase in the number of elderly individuals and life expectancy, as well as industrialization, which is associated with an increased prevalence of Parkinson's disease (PD). However, inconsistent results have recently been reported. Therefore, this study aimed to investigate the prevalence and distribution characteristics of PD among individuals aged 45 years and older.

Methods

Using data from the China Health and Retirement Longitudinal Study (CHARLS), we attempted to estimate the prevalence of PD and its distribution characteristics among 19,034 individuals aged 45 years and older residing in 446 communities/villages within 27 provinces/autonomous regions/municipalities in mainland China. Cases were established based on a doctor's previous diagnosis. Crude and age-adjusted prevalence rates were calculated and stratified by age, sex, area of residence, education level, marital status, and geographic region. Logistic regression models were used to identify risk factors associated with PD.

Results

We identified 178 patients with PD among 19,034 residents aged 45 years and older. The crude prevalence was 0.94%, and the age-adjusted prevalence was 0.82% for individuals aged 45 years and older. The prevalence of PD increased with age (P < 0.001). No significant differences were found in terms of sex, area of residence, or education level. Stratified by geographic region, the prevalence of PD was greater in North and Northwest China and lower in southern China (p < 0.001). Multiple regression analyses showed that age was a significant risk factor for PD.

Conclusion

The prevalence of PD increased with age in the Chinese population.
Literature
1.
go back to reference China NBoSo. 2022 China statistical yearbook. 2022. China NBoSo. 2022 China statistical yearbook. 2022.
2.
go back to reference The L. Population ageing in China: crisis or opportunity? Lancet. 2022;400(10366):1821.CrossRef The L. Population ageing in China: crisis or opportunity? Lancet. 2022;400(10366):1821.CrossRef
4.
go back to reference Qi S, Yin P, Wang L, Qu M, Kan GL, Zhang H, Zhang Q, Xiao Y, Deng Y, Dong Z, et al. Prevalence of Parkinson's disease: a community-based study in China. Mov Disord. 2021;36(12):2940–4.PubMedCrossRef Qi S, Yin P, Wang L, Qu M, Kan GL, Zhang H, Zhang Q, Xiao Y, Deng Y, Dong Z, et al. Prevalence of Parkinson's disease: a community-based study in China. Mov Disord. 2021;36(12):2940–4.PubMedCrossRef
7.
go back to reference Collaborators GBDN. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(5):459–80.CrossRef Collaborators GBDN. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(5):459–80.CrossRef
8.
go back to reference Wanneveich M, Moisan F, Jacqmin-Gadda H, Elbaz A, Joly P. Projections of prevalence, lifetime risk, and life expectancy of Parkinson's disease (2010–2030) in France. Movement Disord: Off J Movement Disord Soc. 2018;33(9):1449–55.CrossRef Wanneveich M, Moisan F, Jacqmin-Gadda H, Elbaz A, Joly P. Projections of prevalence, lifetime risk, and life expectancy of Parkinson's disease (2010–2030) in France. Movement Disord: Off J Movement Disord Soc. 2018;33(9):1449–55.CrossRef
9.
10.
go back to reference Song Z, Liu S, Li X, Zhang M, Wang X, Shi Z, Ji Y. Prevalence of Parkinson’s disease in adults aged 65 years and older in China: a multicenter population-based survey. Neuroepidemiology. 2022;56(1):50–8.PubMedCrossRef Song Z, Liu S, Li X, Zhang M, Wang X, Shi Z, Ji Y. Prevalence of Parkinson’s disease in adults aged 65 years and older in China: a multicenter population-based survey. Neuroepidemiology. 2022;56(1):50–8.PubMedCrossRef
12.
go back to reference Kieburtz K, Wunderle KB. Parkinson's disease: evidence for environmental risk factors. Mov Disord. 2013;28(1):8–13.PubMedCrossRef Kieburtz K, Wunderle KB. Parkinson's disease: evidence for environmental risk factors. Mov Disord. 2013;28(1):8–13.PubMedCrossRef
13.
go back to reference Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43(1):61–8.PubMedCrossRef Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43(1):61–8.PubMedCrossRef
14.
go back to reference China NBoSo. 2021 China statistical yearbook. 2021. China NBoSo. 2021 China statistical yearbook. 2021.
15.
go back to reference Cui L, Hou NN, Wu HM, Zuo X, Lian YZ, Zhang CN, Wang ZF, Zhang X, Zhu JH. Prevalence of Alzheimer's disease and Parkinson's disease in China: an updated systematical analysis. Front Aging Neurosci. 2020;12:603854.PubMedPubMedCentralCrossRef Cui L, Hou NN, Wu HM, Zuo X, Lian YZ, Zhang CN, Wang ZF, Zhang X, Zhu JH. Prevalence of Alzheimer's disease and Parkinson's disease in China: an updated systematical analysis. Front Aging Neurosci. 2020;12:603854.PubMedPubMedCentralCrossRef
16.
go back to reference Wang YS, Shi YM, Wu ZY, He YX, Zhang BZ. Parkinson’s disease in China. Coordinational Group of Neuroepidemiology PLA. Chin Med J. 1991;104(11):960–4.PubMedCrossRef Wang YS, Shi YM, Wu ZY, He YX, Zhang BZ. Parkinson’s disease in China. Coordinational Group of Neuroepidemiology PLA. Chin Med J. 1991;104(11):960–4.PubMedCrossRef
17.
go back to reference Zhang ZX, Roman GC, Hong Z, Wu CB, Qu QM, Huang JB, Zhou B, Geng ZP, Wu JX, Wen HB, et al. Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai. Lancet. 2005;365(9459):595–7.PubMedCrossRef Zhang ZX, Roman GC, Hong Z, Wu CB, Qu QM, Huang JB, Zhou B, Geng ZP, Wu JX, Wen HB, et al. Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai. Lancet. 2005;365(9459):595–7.PubMedCrossRef
18.
go back to reference Rocca WA. The burden of Parkinson's disease: a worldwide perspective. Lancet Neurol. 2018;17(11):928–9.PubMedCrossRef Rocca WA. The burden of Parkinson's disease: a worldwide perspective. Lancet Neurol. 2018;17(11):928–9.PubMedCrossRef
20.
go back to reference Deuschl G, Beghi E, Fazekas F, Varga T, Christoforidi KA, Sipido E, Bassetti CL, Vos T, Feigin VL. The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017. Lancet Publ Health. 2020;5(10):e551–67.CrossRef Deuschl G, Beghi E, Fazekas F, Varga T, Christoforidi KA, Sipido E, Bassetti CL, Vos T, Feigin VL. The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017. Lancet Publ Health. 2020;5(10):e551–67.CrossRef
21.
go back to reference Collaborators GUND, Feigin VL, Vos T, Alahdab F, Amit AML, Barnighausen TW, Beghi E, Beheshti M, Chavan PP, Criqui MH, et al. Burden of Neurological Disorders Across the US From 1990–2017: A Global Burden of Disease Study. JAMA Neurol. 2021;78(2):165–76.CrossRef Collaborators GUND, Feigin VL, Vos T, Alahdab F, Amit AML, Barnighausen TW, Beghi E, Beheshti M, Chavan PP, Criqui MH, et al. Burden of Neurological Disorders Across the US From 1990–2017: A Global Burden of Disease Study. JAMA Neurol. 2021;78(2):165–76.CrossRef
22.
go back to reference Safiri S, Noori M, Nejadghaderi SA, Mousavi SE, Sullman MJM, Araj-Khodaei M, Singh K, Kolahi AA, Gharagozli K. The burden of Parkinson's disease in the Middle East and North Africa region, 1990–2019: results from the global burden of disease study 2019. BMC Public Health. 2023;23(1):107.PubMedPubMedCentralCrossRef Safiri S, Noori M, Nejadghaderi SA, Mousavi SE, Sullman MJM, Araj-Khodaei M, Singh K, Kolahi AA, Gharagozli K. The burden of Parkinson's disease in the Middle East and North Africa region, 1990–2019: results from the global burden of disease study 2019. BMC Public Health. 2023;23(1):107.PubMedPubMedCentralCrossRef
23.
go back to reference Nakagawa T, Cho J, Yeung DY. Successful Aging in East Asia: Comparison Among China, Korea, and Japan. J Gerontol B Psychol Sci Soc Sci. 2021;76(Suppl 1):S17-s26.PubMedCrossRef Nakagawa T, Cho J, Yeung DY. Successful Aging in East Asia: Comparison Among China, Korea, and Japan. J Gerontol B Psychol Sci Soc Sci. 2021;76(Suppl 1):S17-s26.PubMedCrossRef
24.
go back to reference Han S, Kim S, Kim H, Shin HW, Na KS, Suh HS. Prevalence and incidence of Parkinson's disease and drug-induced parkinsonism in Korea. BMC Public Health. 2019;19(1):1328.PubMedPubMedCentralCrossRef Han S, Kim S, Kim H, Shin HW, Na KS, Suh HS. Prevalence and incidence of Parkinson's disease and drug-induced parkinsonism in Korea. BMC Public Health. 2019;19(1):1328.PubMedPubMedCentralCrossRef
25.
go back to reference Yamawaki M, Kusumi M, Kowa H, Nakashima K. Changes in prevalence and incidence of Parkinson's disease in Japan during a quarter of a century. Neuroepidemiology. 2009;32(4):263–9.PubMedCrossRef Yamawaki M, Kusumi M, Kowa H, Nakashima K. Changes in prevalence and incidence of Parkinson's disease in Japan during a quarter of a century. Neuroepidemiology. 2009;32(4):263–9.PubMedCrossRef
26.
go back to reference Ou Z, Pan J, Tang S, Duan D, Yu D, Nong H, Wang Z. Global Trends in the Incidence, Prevalence, and Years Lived With Disability of Parkinson's Disease in 204 Countries/Territories From 1990 to 2019. Front Public Health. 2021;9.PubMedPubMedCentralCrossRef Ou Z, Pan J, Tang S, Duan D, Yu D, Nong H, Wang Z. Global Trends in the Incidence, Prevalence, and Years Lived With Disability of Parkinson's Disease in 204 Countries/Territories From 1990 to 2019. Front Public Health. 2021;9.PubMedPubMedCentralCrossRef
27.
28.
go back to reference The Lancet N. Parkinson's disease needs an urgent public health response. Lancet Neurol. 2022;21(9):759.CrossRef The Lancet N. Parkinson's disease needs an urgent public health response. Lancet Neurol. 2022;21(9):759.CrossRef
29.
go back to reference Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch S, Croteau D, Bohr V. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019;15(10):565–81.PubMedCrossRef Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch S, Croteau D, Bohr V. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019;15(10):565–81.PubMedCrossRef
30.
go back to reference Pringsheim T, Jette N, Frolkis A, Steeves TD. The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2014;29(13):1583–90.PubMedCrossRef Pringsheim T, Jette N, Frolkis A, Steeves TD. The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2014;29(13):1583–90.PubMedCrossRef
31.
go back to reference Eusebi P, Franchini D, De Giorgi M, Abraha I, Montedori A, Casucci P, Calabresi P, Tambasco N. Incidence and prevalence of Parkinson’s disease in the Italian region of Umbria: a population-based study using healthcare administrative databases. Neurol Sci. 2019;40(8):1709–12.PubMedCrossRef Eusebi P, Franchini D, De Giorgi M, Abraha I, Montedori A, Casucci P, Calabresi P, Tambasco N. Incidence and prevalence of Parkinson’s disease in the Italian region of Umbria: a population-based study using healthcare administrative databases. Neurol Sci. 2019;40(8):1709–12.PubMedCrossRef
32.
go back to reference Collier T, Kanaan N, Kordower J. Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates. Nat Rev Neurosci. 2011;12(6):359–66.PubMedPubMedCentralCrossRef Collier T, Kanaan N, Kordower J. Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates. Nat Rev Neurosci. 2011;12(6):359–66.PubMedPubMedCentralCrossRef
33.
35.
go back to reference Collier TJ, Lipton J, Daley BF, Palfi S, Chu Y, Sortwell C, Bakay RA, Sladek JR Jr, Kordower JH. Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism. Neurobiol Dis. 2007;26(1):56–65.PubMedPubMedCentralCrossRef Collier TJ, Lipton J, Daley BF, Palfi S, Chu Y, Sortwell C, Bakay RA, Sladek JR Jr, Kordower JH. Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism. Neurobiol Dis. 2007;26(1):56–65.PubMedPubMedCentralCrossRef
37.
go back to reference Benito-Leon J, Bermejo-Pareja F, Rodriguez J, Molina JA, Gabriel R, Morales JM. Neurological Disorders in Central Spain Study G: Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain. Mov Disord. 2003;18(3):267–74.PubMedCrossRef Benito-Leon J, Bermejo-Pareja F, Rodriguez J, Molina JA, Gabriel R, Morales JM. Neurological Disorders in Central Spain Study G: Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain. Mov Disord. 2003;18(3):267–74.PubMedCrossRef
38.
go back to reference Wright Willis A, Evanoff BA, Lian M, Criswell SR, Racette BA. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology. 2010;34(3):143–51.PubMedPubMedCentralCrossRef Wright Willis A, Evanoff BA, Lian M, Criswell SR, Racette BA. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology. 2010;34(3):143–51.PubMedPubMedCentralCrossRef
39.
go back to reference Kizza J, Lewington S, Mappin-Kasirer B, Turnbull I, Guo Y, Bian Z, Chen Y, Yang L, Chen Z, Clarke R. Cardiovascular risk factors and Parkinson’s disease in 500,000 Chinese adults. Ann Clin Transl Neurol. 2019;6(4):624–32.PubMedPubMedCentralCrossRef Kizza J, Lewington S, Mappin-Kasirer B, Turnbull I, Guo Y, Bian Z, Chen Y, Yang L, Chen Z, Clarke R. Cardiovascular risk factors and Parkinson’s disease in 500,000 Chinese adults. Ann Clin Transl Neurol. 2019;6(4):624–32.PubMedPubMedCentralCrossRef
40.
go back to reference Fardell C, Torén K, Schiöler L, Nissbrandt H, Åberg M. High IQ in Early Adulthood Is Associated with Parkinson's Disease. J Parkinsons Dis. 2020;10(4):1649–56.PubMedPubMedCentralCrossRef Fardell C, Torén K, Schiöler L, Nissbrandt H, Åberg M. High IQ in Early Adulthood Is Associated with Parkinson's Disease. J Parkinsons Dis. 2020;10(4):1649–56.PubMedPubMedCentralCrossRef
41.
go back to reference Osler M, Okholm GT, Villumsen M, Rozing MP, Jørgensen TSH. Associations of Young Adult Intelligence, Education, Height, and Body Mass Index with Subsequent Risk of Parkinson's Disease and Survival: A Danish Cohort Study. J Parkinsons Dis. 2022;12(3):1035–43.PubMedCrossRef Osler M, Okholm GT, Villumsen M, Rozing MP, Jørgensen TSH. Associations of Young Adult Intelligence, Education, Height, and Body Mass Index with Subsequent Risk of Parkinson's Disease and Survival: A Danish Cohort Study. J Parkinsons Dis. 2022;12(3):1035–43.PubMedCrossRef
42.
go back to reference Frigerio R, Elbaz A, Sanft K, Peterson B, Bower J, Ahlskog J, Grossardt B, de Andrade M, Maraganore D, Rocca W. Education and occupations preceding Parkinson disease: a population-based case-control study. Neurology. 2005;65(10):1575–83.PubMedCrossRef Frigerio R, Elbaz A, Sanft K, Peterson B, Bower J, Ahlskog J, Grossardt B, de Andrade M, Maraganore D, Rocca W. Education and occupations preceding Parkinson disease: a population-based case-control study. Neurology. 2005;65(10):1575–83.PubMedCrossRef
43.
go back to reference de Rijk M, Tzourio C, Breteler M, Dartigues J, Amaducci L, Lopez-Pousa S, Manubens-Bertran J, Alpérovitch A, Rocca W. Prevalence of parkinsonism and Parkinson’s disease in Europe: the EUROPARKINSON collaborative study European community concerted action on the epidemiology of Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1997;62(1):10–5.PubMedPubMedCentralCrossRef de Rijk M, Tzourio C, Breteler M, Dartigues J, Amaducci L, Lopez-Pousa S, Manubens-Bertran J, Alpérovitch A, Rocca W. Prevalence of parkinsonism and Parkinson’s disease in Europe: the EUROPARKINSON collaborative study European community concerted action on the epidemiology of Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1997;62(1):10–5.PubMedPubMedCentralCrossRef
44.
go back to reference Zirra A, Rao SC, Bestwick J, Rajalingam R, Marras C, Blauwendraat C, Mata IF, Noyce AJ. Gender differences in the prevalence of Parkinson’s disease. Movement Disord Clin Pract. 2023;10(1):86–93.CrossRef Zirra A, Rao SC, Bestwick J, Rajalingam R, Marras C, Blauwendraat C, Mata IF, Noyce AJ. Gender differences in the prevalence of Parkinson’s disease. Movement Disord Clin Pract. 2023;10(1):86–93.CrossRef
45.
go back to reference Rocca WA, Anderson DW, Meneghini F, Grigoletto F, Morgante L, Reggio A, Savettieri G, Di Perri R. Occupation, education, and Parkinson's disease: a case-control study in an Italian population. Mov Disord. 1996;11(2):201–6.PubMedCrossRef Rocca WA, Anderson DW, Meneghini F, Grigoletto F, Morgante L, Reggio A, Savettieri G, Di Perri R. Occupation, education, and Parkinson's disease: a case-control study in an Italian population. Mov Disord. 1996;11(2):201–6.PubMedCrossRef
46.
go back to reference Ayton D, Ayton S, Barker AL, Bush AI, Warren N. Parkinson's disease prevalence and the association with rurality and agricultural determinants. Parkinsonism Relat Disord. 2019;61:198–202.PubMedCrossRef Ayton D, Ayton S, Barker AL, Bush AI, Warren N. Parkinson's disease prevalence and the association with rurality and agricultural determinants. Parkinsonism Relat Disord. 2019;61:198–202.PubMedCrossRef
47.
go back to reference Di Luca DG, Feldman M, Jimsheleishvili S, Margolesky J, Cordeiro JG, Diaz A, Shpiner DS, Moore HP, Singer C, Li H, et al. Trends of inpatient palliative care use among hospitalized patients with Parkinson's disease. Parkinsonism Relat Disord. 2020;77:13–7.PubMedCrossRef Di Luca DG, Feldman M, Jimsheleishvili S, Margolesky J, Cordeiro JG, Diaz A, Shpiner DS, Moore HP, Singer C, Li H, et al. Trends of inpatient palliative care use among hospitalized patients with Parkinson's disease. Parkinsonism Relat Disord. 2020;77:13–7.PubMedCrossRef
48.
go back to reference Yip W, Fu H, Chen AT, Zhai T, Jian W, Xu R, Pan J, Hu M, Zhou Z, Chen Q, et al. 10 years of health-care reform in China: progress and gaps in Universal Health Coverage. Lancet. 2019;394(10204):1192–204.PubMedCrossRef Yip W, Fu H, Chen AT, Zhai T, Jian W, Xu R, Pan J, Hu M, Zhou Z, Chen Q, et al. 10 years of health-care reform in China: progress and gaps in Universal Health Coverage. Lancet. 2019;394(10204):1192–204.PubMedCrossRef
49.
go back to reference Ascherio A, Schwarzschild MA. The epidemiology of Parkinson's disease: risk factors and prevention. Lancet Neurol. 2016;15(12):1257–72.PubMedCrossRef Ascherio A, Schwarzschild MA. The epidemiology of Parkinson's disease: risk factors and prevention. Lancet Neurol. 2016;15(12):1257–72.PubMedCrossRef
50.
go back to reference Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C. The epidemiology of Parkinson's disease. Lancet. 2024;403(10423):283–92.PubMedCrossRef Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C. The epidemiology of Parkinson's disease. Lancet. 2024;403(10423):283–92.PubMedCrossRef
Metadata
Title
Prevalence of Parkinson’s disease among adults aged 45 years and older in China: a cross-sectional study based on the China health and retirement longitudinal study
Authors
Detao Meng
Jiayu Wu
Xinyu Huang
Xiaoxiao Liang
Boyan Fang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-18653-0

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue